Christoph Herrmann

Metabolomic Discoveries GmbH provides research and analytical services focusing on global metabolite profiling and fingerprinting. The firm uses technologies such as gas chromatography-mass spectrometry systems, Quadrupole time-of-flight mass spectrometers coupled to an ultra performance liquid chromatograph, Triple-Quadrupole mass spectrometer with ultrafast technology to analyze known and unknown metabolites in a sample. Its services include metabolite profiling, study of the lipidome, central metabolism quantification profiling, flavor profiling, measurement of non-organic or mineral elements in a biological sample, and flux analysis. The company was founded by Sandra Trenkamp and Nicolas Schauer in 2009 and is headquartered in Potsdam-Golm, Germany.

GILUPI GmbH develops and produces products for the in-vivo isolation of rare cells from the circulation. Its product GILUPI CellCollector enables the detection of rare cells directly from the blood of patients. The company was founded by Klaus Lücke, Ulrich Pison, Michael Giersig, and Fabian Rüchardt in 2006 and is headquartered in Potsdam, Germany.